Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWPhenylpyruvic acid is an active metabolite of the essential amino acid L-phenylalanine (Item No. 31498) and a biosynthetic precursor to the antifungal phenyl alkanoic acid 3-phenyllactic acid (Item No. 36365).1,2 It inhibits glucose-6-phosphate dehydrogenase (G6PDH) in rat brain homogenates when used at concentrations of 0.6 and 1.2 mM.1 Addition of phenylpyruvic acid to the culture medium of lactic acid bacteria increases 3-phenyllactic acid levels in, and the antifungal activity of, the cell-free culture supernatant.2 Urinary levels of phenylpyruvic acid are increased in patients with phenylketonuria (PKU), an inborn error of metabolism characterized by a deficiency in phenylalanine hydroxylase (PAH) activity.3
WARNING This product is not for human or veterinary use.
1. Phenylpyruvic acid decreases glucose-
2. Improvement of the antifungal activity of lactic acid bacteria by addition to the growth medium of phenylpyruvic acid, a precursor of phenyllactic acid. Int. J. Food Microbiol. 222, 1-7 (2016).
3. A GC/MS-